Lymphocyte subset is more suitable than systemic inflammatory response biomarker and immunoglobulin in constructing prognostic nomogram model for advanced gastric cancer

Tianyi Fang(Harbin Medical University), Yingwei Xue(Harbin Medical University), Yimin Wang(Harbin Medical University), Lei Zhang(Zhengzhou University), Xudong Zhao(China Medical University), Xuan Lin(Beijing Technology and Business University), Xin Yin(South China University of Technology), Xinghai Zhang(Chinese Academy of Sciences), Yufei Wang(Chinese PLA General Hospital)
Heliyon
March 1, 2023
10.1016/j.heliyon.2023.e14669
Cited by 3

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
|Journal of Experimental & Clinical Cancer Research|2019|324
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
|Lipids in Health and Disease|2017|298
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial
|Gut Microbes|2023|184
The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients
|Scientific Reports|2021|143